CAMS Innovation Fund for Medical Sciences(CIFMS)(2021-I2M-1-061 and 2021-1-I2M-003);CSCO-hengrui Cancer Research Fund(Y-HR2019-0239);CSCO-MSD Cancer Research Fund(Y-MSDZD2021-0213);National Ten-thousand Talent Program(to J.L.);Young Scientists Fund of the National Natural Science Foundation of China(82303720);Beijing Natural Science Foundation(7234381);Fundamental Research Funds for the Central Universities(3332023011 to J.L.).
Background:Hepatocholangiocarcinoma(H-ChC)has the clinicopathological features of both hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(iCCA)and is a more aggressive subtype of primary hepatic carcinom...
supported by the National Natural Science Foundation of China[82160578];the Natural Science Foundation of Jiangxi Province[20212BCJ23024];the Health Department of Jiangxi Province[202130346].
The low incidence of combined hepatocellular cholangiocarcinoma(cHCC-CCA)is an important factor limiting research progression.Our study extensively included nearly three decades of relevant literature and assembled th...